Neeraj Deewan of Quantum Securities told CNBC-TV18, "I don't think there is too much upside in Glenmark Pharma based on what the valuation it is trading on right now. Our target will be close to Rs 900 odd in the stock for next 5-6 months."Glenmark Pharma closed at Rs 853.10, up Rs 19.90, or 2.39 percent. It has touched an intraday high of Rs 856.50 and an intraday low of Rs 845.00.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
